ClinicalTrials.govpublic full text
The Effect of Nafamostat Mesilate in Prolonging Filter Patency With Patients on Continuous Renal Replacement Therapy
acute kidney injury, nafamostat mesilate, heparin, continuous renal replacement therapy, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 846075
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.